Zydus Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 172.50 Cr
- Paid Up Capital ₹ 100.62 Cr
- Company Age 29 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1,500.00 Cr
- Satisfied Charges ₹ 3,001.83 Cr
- Revenue Growth 13.72%
- Profit Growth 78.25%
- Ebitda 27.96%
- Net Worth 3.01%
- Total Assets 15.92%
About Zydus Lifesciences
Zydus Lifesciences Limited (ZLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 15 May 1995 and has a history of 29 years and nine months. Its registered office is in Ahmedabad, Gujarat, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532321 and on the National Stock Exchange(NSE) under CADILAHC.
The Corporate was formerly known as Cadila Healthcare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 172.50 Cr and a paid-up capital of Rs 100.62 Cr.
The company currently has active open charges totaling ₹1,500.00 Cr. The company has closed loans amounting to ₹3,001.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Zydus Lifesciences Limited India are Dhavlal Soni as COMPANY SECRETARY and Nitinkumar Parekh as Cfo. Upasana Konidela, Shelina Parikh, Pankaj Patel, and Six other members serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
Industry
Pharma
What products or services does Zydus Lifesciences Limited offer?
Zydus Lifesciences Limited offers a wide range of products and services, including Pharmaceutical Services, Biotechnology Services.
Who are the key members and board of directors at Zydus Lifesciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharvil Patel  | Managing Director | 01-Aug-1997 | Current |
| Nitinkumar Parekh | CFO | 10-Feb-2015 | Current |
| Dhavlal Soni | Company Secretary | 07-Feb-2019 | Current |
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mukesh Patel | Director | 01-Aug-1997 | Current |
| Ganesh Nayak | Whole-Time Director | 12-Jul-2017 | Current |
| Upasana Konidela | Director | 29-Nov-2022 | Current |
| Shelina Parikh | Director | 17-May-2024 | Current |
| Pankaj Patel | Director | 15-May-1995 | Current |
| Bhadresh Shah | Director | 06-Dec-2018 | Current |
Financial Performance of Zydus Lifesciences.
Zydus Lifesciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.72% increase. The company also saw a substantial improvement in profitability, with a 78.25% increase in profit. The company's net worth moved up by a moderate rise of 3.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zydus Lifesciences?
In 2024, Zydus Lifesciences had a promoter holding of 74.98% and a public holding of 25.01%. The company had 16 Subsidiaries and 3 Joint Ventures. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zydus Wellness Products LimitedSharvil Patel is a mutual person
Zydus Wellness LimitedGanesh Nayak, Sharvil Patel and 1 more are mutual person
Zydus Hospira Oncology Private LimitedGanesh Nayak is a mutual person
Zydus FoundationPankaj Patel and Sharvil Patel are mutual person
Tuv India P LtdApurva Diwanji is a mutual person
Zydus Takeda Healthcare Private LimitedPankaj Patel and Ganesh Nayak are mutual person
Charges (Loans)
Open Charges
₹1,500.00 Cr
Satisfied Charges
₹3,001.83 Cr
Charges Breakdown by Lending Institutions
- Others : 1500.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Dec 2012 | Others | ₹1,500.00 Cr | Open |
| 24 Dec 2015 | Citi Bank N.A. | ₹225.00 Cr | Satisfied |
| 07 Aug 2014 | Citi Bank N.A. | ₹93.00 Cr | Satisfied |
| 28 May 2014 | Others | ₹120.40 Cr | Satisfied |
| 21 Nov 2013 | Citi Bank N.A. | ₹94.50 Cr | Satisfied |
How Many Employees Work at Zydus Lifesciences?
Zydus Lifesciences has a workforce of 13762 employees as of Jan 16, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zydus Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zydus Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Zydus Lifesciences
Recent activity within the organization
- Annual General Meeting
Zydus Lifesciences Limited last Annual general meeting of members was held on 09 Aug 2024 as per latest MCA records.
- Director Appointment
Shelina Pranav Parikh was appointed as a Director was appointed as a Director on 17 May 2024 & has been associated with this company since 9 months 15 days .
- Balance Sheet
Zydus Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
- Director Appointment
Upasana Konidela was appointed as a Director was appointed as a Director on 29 Nov 2022 & has been associated with this company since 2 years 3 months .
- Director Appointment
Monappa Arun Akhil was appointed as a Director was appointed as a Director on 29 Nov 2022 & has been associated with this company since 2 years 3 months .
- Charges
A charge with Others of Rs. 1,500.00 Cr registered on 21 Dec 2012 with Charge ID 10396390 was modified on 20 Apr 2022.
Recent News, Updates & Announcement
- Zydus Lifesciences Buyback 2024 News: Leading Drug Firm Fixes Share Repurchase Dates: Check Record And Other D.
Zydus Lifesciences Ltd., the pharmaceutical company, announced its equity share buyback on Tuesday. Check buy-back dates, price and other Details..
- Zydus Lifesciences launches advanced prostate cancer drug Rexigo.
The drug will be manufactured at the group’s manufacturing premises Zydus Lifesciences has launched Relugolix under the brand name, Rexigo. This is the first and only oral once-a-day therapy for testo.
Frequently asked questions
What is the Incorporation or founding date of Zydus Lifesciences Limited?
Zydus Lifesciences Limited was incorporated on 15 May 1995.
What is authorized share capital and paid-up capital of Zydus Lifesciences Limited?
The authorized share capital of Zydus Lifesciences Limited is ₹ 172.50 Cr and paid-up capital is ₹ 100.62 Cr.
Who are the current board members & directors of Zydus Lifesciences Limited?
Currently 11 directors are associated with Zydus Lifesciences Limited.
- Dhavlal Narendra Soni
- Nitinkumar Dalsukhray Parekh
- Upasana Konidela
- Shelina Pranav Parikh
- Pankaj Ramanbhai Patel
- Bhadresh Kantilal Shah
- Mukesh Mangalbhai Patel
- Apurva Shishir Diwanji
- Ganesh Narayan Nayak
- Sharvil Pankajbhai Patel
- Monappa Arun Akhil
What is the registered address of Zydus Lifesciences Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Zydus Lifesciences Limited is Zydus Corporate Park Scheme No. 63 Survey 536 Khoraj(Gandhinagar) Nr. Vaishnodevi Circ Le, India, Ahmedabad, Gujarat, 382481.
What is the corporate identification number (CIN) and company number of Zydus Lifesciences Limited?
The corporate identification number (CIN) of Zydus Lifesciences Limited is L24230GJ1995PLC025878 and the company number is 025878 as per Ministry of Corporate Affairs (MCA).
Is Zydus Lifesciences Limited registered with any stock exchange in India?
Yes, Zydus Lifesciences Limited is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): CADILAHC.
What is the official website of Zydus Lifesciences Limited?
The Official website of Zydus Lifesciences Limited is https://www.zyduslife.com
What has been the recent revenue trend for Zydus Lifesciences Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Zydus Lifesciences Limited has risen by 13.72%.
How many employees does Zydus Lifesciences Limited currently have?
As Per 2023 financial reports, 13762 employees are currently employed by Zydus Lifesciences Limited.
What change has been observed in the net worth of Zydus Lifesciences Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Zydus Lifesciences Limited has experienced an upsurge of 3.01%.
What are the total open charges for Zydus Lifesciences Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Zydus Lifesciences Limited amount to ₹ 1,500.00 Cr.
When was the last Balance Sheet of Zydus Lifesciences Limited filed with the ROC?
The most recent Balance Sheet for Zydus Lifesciences Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
Dharmishta RavalDirectorHD
Humayun DhanrajgirDirectorPP
Pranlal PatelDirectorHB
Homi BilpodiwalaDirectorND
Nitin DesaiDirector
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Mumbai, Maharashtra, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India